Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
2004
44.1K+
LTM Revenue $5.3B
LTM EBITDA $514M
$4.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Select Medical has a last 12-month revenue (LTM) of $5.3B and a last 12-month EBITDA of $514M.
In the most recent fiscal year, Select Medical achieved revenue of $5.2B and an EBITDA of $507M.
Select Medical expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Select Medical valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $5.3B | XXX | $5.2B | XXX | XXX | XXX |
Gross Profit | $402M | XXX | $634M | XXX | XXX | XXX |
Gross Margin | 8% | XXX | 12% | XXX | XXX | XXX |
EBITDA | $514M | XXX | $507M | XXX | XXX | XXX |
EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
EBIT | $310M | XXX | $268M | XXX | XXX | XXX |
EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
Net Profit | $184M | XXX | $214M | XXX | XXX | XXX |
Net Margin | 3% | XXX | 4% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $1.7B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Select Medical's stock price is $15.
Select Medical has current market cap of $2.0B, and EV of $4.7B.
See Select Medical trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$4.7B | $2.0B | XXX | XXX | XXX | XXX | $1.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Select Medical has market cap of $2.0B and EV of $4.7B.
Select Medical's trades at 0.9x EV/Revenue multiple, and 9.3x EV/EBITDA.
Equity research analysts estimate Select Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Select Medical has a P/E ratio of 10.7x.
See valuation multiples for Select Medical and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
EV (current) | $4.7B | XXX | $4.7B | XXX | XXX | XXX |
EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
EV/EBITDA | 9.1x | XXX | 9.3x | XXX | XXX | XXX |
EV/EBIT | 15.1x | XXX | 17.5x | XXX | XXX | XXX |
EV/Gross Profit | 11.7x | XXX | n/a | XXX | XXX | XXX |
P/E | 10.7x | XXX | 9.2x | XXX | XXX | XXX |
EV/FCF | 17.5x | XXX | 15.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSelect Medical's last 12 month revenue growth is 5%
Select Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $8K for the same period.
Select Medical's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Select Medical's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Select Medical and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
EBITDA Growth | 5% | XXX | -19% | XXX | XXX | XXX |
Rule of 40 | 17% | XXX | 15% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Select Medical acquired XXX companies to date.
Last acquisition by Select Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Select Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Select Medical founded? | Select Medical was founded in 2004. |
Where is Select Medical headquartered? | Select Medical is headquartered in United States of America. |
How many employees does Select Medical have? | As of today, Select Medical has 44.1K+ employees. |
Who is the CEO of Select Medical? | Select Medical's CEO is Mr. David S. Chernow. |
Is Select Medical publicy listed? | Yes, Select Medical is a public company listed on NYS. |
What is the stock symbol of Select Medical? | Select Medical trades under SEM ticker. |
When did Select Medical go public? | Select Medical went public in 2009. |
Who are competitors of Select Medical? | Similar companies to Select Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Select Medical? | Select Medical's current market cap is $2.0B |
What is the current revenue of Select Medical? | Select Medical's last 12 months revenue is $5.3B. |
What is the current revenue growth of Select Medical? | Select Medical revenue growth (NTM/LTM) is 5%. |
What is the current EV/Revenue multiple of Select Medical? | Current revenue multiple of Select Medical is 0.9x. |
Is Select Medical profitable? | Yes, Select Medical is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Select Medical? | Select Medical's last 12 months EBITDA is $514M. |
What is Select Medical's EBITDA margin? | Select Medical's last 12 months EBITDA margin is 10%. |
What is the current EV/EBITDA multiple of Select Medical? | Current EBITDA multiple of Select Medical is 9.1x. |
What is the current FCF of Select Medical? | Select Medical's last 12 months FCF is $268M. |
What is Select Medical's FCF margin? | Select Medical's last 12 months FCF margin is 5%. |
What is the current EV/FCF multiple of Select Medical? | Current FCF multiple of Select Medical is 17.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.